CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The goal of this clinical trial is to assess if circulating tumor DNA can guide adjuvant selection in high-intermediate risk early-stage endometrial...
Birmingham, Alabama, United States and 11 other locations
This is a single arm, Phase II study using the combination of atezolizumab and bevicacizumab in women with advanced, recurrent or persistent endometrial...
Phase 2
Birmingham, Alabama, United States and 2 other locations
global, multi-arm study to evaluate efficacy and safety of relacorilant in combination with other treatments in patients with gynecological cancers...
Phase 2
Birmingham, Alabama, United States and 48 other locations
antitumor activity of IMGN151 in adult participants with recurrent endometrial cancer; recurrent, high-grade serous epithelial ovar...
Phase 1
Birmingham, Alabama, United States and 57 other locations
can be given alone or with cemiplimab to patients with ovarian cancer or cancer of the uterus* The study will also look at the leve...
Phase 1, Phase 2
Birmingham, Alabama, United States and 55 other locations
The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...
Phase 3
Birmingham, Alabama, United States and 232 other locations
besides treating your disease.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be removed w...
Phase 1
Birmingham, Alabama, United States and 61 other locations
The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-M07D1 in patients with HER2 expressing advanced tumors.
Phase 1
Birmingham, Alabama, United States and 25 other locations
The main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally ad...
Phase 1
Birmingham, Alabama, United States and 46 other locations
with the exception of people with advanced non-small cell lung cancer (NSCLC).Solid tumors may have specific changes or mutations to a gene ...
Phase 2
Birmingham, Alabama, United States and 55 other locations
Clinical trials
Research sites
Resources
Legal